Johnson & Johnson (JNJ)


NYSE - NYSE Real Time Price. Currency in USD
119.39+0.17 (+0.14%)
At close: 4:00 PM EDT

119.39 0.00 (0.00%)
After hours: 7:04 PM EDT

People also watch:
PGMRKKOPFEXOM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open119.05
Prev Close119.22
Bid119.22 x 400
Ask119.57 x 500
Day's Range118.81 - 119.52
52wk Range91.76 - 126.07
1y Target EstN/A
Market Cap326.64B
P/E Ratio (ttm)22.25
Beta0.70
Volume4,958,265
Avg Vol (3m)6,432,098
Dividend & Yield3.20 (2.72%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters50 minutes ago

    U.S. FDA approves Medtronic's 'artificial pancreas' for diabetes

    Medtronic Plc won U.S. approval on Wednesday for an "artificial pancreas" that is the first device to automatically deliver the right dose of insulin to patients with type 1 diabetes, freeing them from continually monitoring insulin levels throughout each day. The U.S. Food and Drug Administration, in its approval of the device, the MiniMed 670G, hailed it as a breakthrough. The device offers type 1 diabetics "greater freedom to live their lives without having to consistently and manually monitor baseline glucose levels and administer insulin," Dr. Jeffrey Shuren, director of the FDA's medical device division, said in a statement.

  • Associated Press3 hours ago

    FDA approves 'artificial pancreas' to manage diabetes

    Federal regulators have approved a first-of-a-kind "artificial pancreas," a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering ...

  • Better Buy: Johnson & Johnson vs. AbbVie
    Motley Fool5 hours ago

    Better Buy: Johnson & Johnson vs. AbbVie

    These big pharma stocks have done well for investors lately, but which is the smarter pick now?